How To Identify and Treat Inner Knee Pain

Health & Lifestyle
677

Listen to article (english)

Translate to Spanish or other 102 languages!

Injuries and arthritis are two possible causes of inner knee pain. Treatment options depend on the cause and include warm or cold packs, exercise, and medication. Image for illustration purposes
Injuries and arthritis are two possible causes of inner knee pain. Treatment options depend on the cause and include warm or cold packs, exercise, and medication. Image for illustration purposes

Medical News Today

- Advertisement -

Injuries and arthritis are two possible causes of inner knee pain. Treatment options depend on the cause and include warm or cold packs, exercise, and medication.

The inner or medial knee refers to the part closest to the other knee.

This article describes types of inner knee pain, their treatment, and exercises that can help.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/321065?slot_pos=article_3&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-02-13&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
AI Powered Stethoscopes Improve Access to Heart Care
Next article
Five Things Parents Need to know to Keep Kids’ Hearts Healthy

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -